The global cystic fibrosis market was valued at approximately USD 5.2 billion in 2024 and is expected to grow at a CAGR of around 7.8% from 2024 to 2034. Growth is fueled by the rising prevalence of cystic fibrosis worldwide, increased adoption of advanced therapies, and a growing pipeline